Come along to our upcoming Parents’ Night Out with the Scientists. This event will be held during National Carers Week to celebrate the carers in our community.
When: Saturday October 12, 2024
Where: The Balmoral Hotel, Vic Park.
Time: 6:30pm presentation from Wal-Yan Respiratory Research Centre followed by dinner at 7:30pm.
Cost: $30 per person
RSVP here by Friday September 27.
This event is possible thanks to funding from Carers WA and Lotterywest!
Wal-yan Respiratory Presentation
We are excited to be joined by researchers Anthony Kicic, Daniel Laurcirica and Rohan Flint who will present on “From Land to Lab then Lung; Translating Bacteriophage to Treat Difficult Respiratory Infections”.
Anthony is currently Head of Airway Epithelial Research at the Kids Research Institute Australia and is Associate Professor at the School of Population Health, Curtin University. He successfully runs a paediatric and adult 3D primary lung model research program, using cells collected from healthy and diseased cohorts. Using these, he models and investigates host-pathogen interactions, infection establishment and novel therapies including bacteriophage, to treat chronic pulmonary bacterial infections in CF.
Daniel is a postdoctoral researcher with extensive experience studying viruses and bacteria. For his PhD thesis he studied the interplay between infection, inflammation, and immune cell activity in the lungs of children with cystic fibrosis, identifying that specific bacterial infections trigger lung damage. Currently, he manages the phage-matching service at Phage WA, identifying which phages are the best choice for treating patients requesting phage therapy. His own research project looks at the effects of phage therapy on the immune response in the lungs, exploring how phages may improve the function of immune cells fighting infection.
Rohan is a 3rd year PhD Student within Respiratory Centre via the University of Western Australia. His project focuses on the use of aerosolisation to deliver phages to the lungs for treating respiratory bacterial infections. He is interested in the use of aerosolisation technologies for delivering therapeutic drugs to the lungs and airways.